The REVERSE Project- pREVention and management tools for rEducing antibiotic Resistance in high prevalence SEttings. 

REVERSE is an EU Horizon 2020 project (July 2021 - June 2026) that aims to develop and implement cost-effective strategies and tools for the prevention and clinical management of healthcare-associated infections due to multidrug-resistant pathogens and to reduce the burden of antimicrobial resistance in high prevalence healthcare settings.

The project consortium includes 12 partners in 8 countries, and is coordinated by the University of Zurich in Switzerland.

REVERSE has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 965265.
The content in this profile reflects only the author's review. The European Commission is not responsible for any use that may be made of the information it contains.

#antimicrobialresistance #AMR #antibioticstewardship #horizoneurope #horizon2020 #HCIs #ImpSci

REVERSE Project

Org chart

Teams

Offices